ENHANCEMENT OF IL-6 RECEPTOR-BETA CHAIN (GP130) EXPRESSION BY IL-6, IL-1 AND TNF IN HUMAN EPITHELIAL-CELLS

被引：37
|
作者：
SNYERS, L
CONTENT, J
机构：
[1] Institut Pasteur du Brabant, Department of Virology, 1180 Bruxelles
来源：
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 1992年 / 185卷 / 03期
关键词：
D O I：
10.1016/0006-291X(92)91712-Y
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Analysis of the IL-6 Receptor β chain (gp130) mRNA expression on the two human epithelial cell lines UAC and Hep3B reveals that it is enhanced by IL-6, IL-1 and TNF treatment. In the case of UAC cells, TNF action might be mediated by IL-6. For Hep3B cells, TNF seems to exert a direct effect on gp130, as no IL-6 expression is detected after stimulation by this cytokine. On the same cells, increase of the binding of an anti-gp130 monoclonal antibody was observed after treatment by TNF, which denotes the effective appearance of new gp130 molecules on the cell surface. All this cytokines seem to act selectively on the β chain of the IL-6 receptor. This probably reflects the importance for some cells to have gp130 represented on their membrane in inflammatory contexts. © 1992.
引用
收藏
页码：902 / 908
页数：7
相关论文
共 50 条
  • [31] IL-6/gp130 signaling: a key unlocking regeneration
    Li, Ruopu
    Li, Deqiang
    Nie, Yu
    CELL REGENERATION, 2023, 12 (01)
  • [32] Granulocytes Are Unresponsive to IL-6 Due to an Absence of gp130
    Wilkinson, Andrew N.
    Gartlan, Kate H.
    Kelly, Greg
    Samson, Luke D.
    Olver, Stuart D.
    Avery, Judy
    Zomerdijk, Nienke
    Tey, Siok-Keen
    Lee, Jason S.
    Vuckovic, Slavica
    Hill, Geoffrey R.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (10): : 3547 - 3555
  • [33] Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis
    Hasegawa, M
    Sato, S
    Fujimoto, M
    Ihn, H
    Kikuchi, K
    Takehara, K
    JOURNAL OF RHEUMATOLOGY, 1998, 25 (02) : 308 - 313
  • [34] TRUNCATED, FUNCTIONAL IL-6 RECEPTOR EXPRESSION IN MURINE MYELOMA CELLS ASSOCIATED WITH LOW GP130 EXPRESSION
    BELLIDO, T
    JILKA, RL
    LIN, SC
    GRIGORIEVA, I
    BARLOGIE, B
    MANOLAGAS, SC
    EPSTEIN, J
    BLOOD, 1994, 84 (10) : A171 - A171
  • [35] In vivo targeting with monoclonal antibodies against gp130 but not IL-6 or IL-6 receptor blocks plasmacytoma cell growth completely
    Burger, R.
    Staudinger, M.
    Peipp, M.
    Wijdenes, J.
    Guenther, A.
    Gramatzki, M.
    ONKOLOGIE, 2013, 36 : 213 - 214
  • [36] MOLECULAR-CLONING AND EXPRESSION OF AN IL-6 SIGNAL TRANSDUCER, GP130
    HIBI, M
    MURAKAMI, M
    SAITO, M
    HIRANO, T
    TAGA, T
    KISHIMOTO, T
    CELL, 1990, 63 (06) : 1149 - 1157
  • [37] Autocrine influence of IL-15 on keratinocyte IL-1 beta, IL-6, and TNF alpha expression
    Mohamadzadeh, M
    Dougherty, I
    Cruz, PD
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (04) : 796 - 796
  • [38] Identification of a novel antigenic domain of the human receptor for IL-6 involved in its interaction with the gp130 chain
    Gaillard, JP
    Liautard, J
    Suarez, JMF
    Klein, B
    Brochier, J
    TISSUE ANTIGENS, 1996, 48 (4-II): : CR202 - CR202
  • [39] IL-1 AND IL-6 IN PSORIASIS
    PRENS, EP
    VANDAMME, J
    BAKKUS, M
    BRAKEL, K
    BENNER, R
    VANJOOST, T
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 93 (04) : 570 - 570
  • [40] CORRELATIONS AND INTERACTIONS IN THE PRODUCTION OF INTERLEUKIN-6 (IL-6), IL-1, AND TUMOR NECROSIS FACTOR (TNF) IN HUMAN-BLOOD MONONUCLEAR-CELLS - IL-6 SUPPRESSES IL-1 AND TNF
    SCHINDLER, R
    MANCILLA, J
    ENDRES, S
    GHORBANI, R
    CLARK, SC
    DINARELLO, CA
    BLOOD, 1990, 75 (01) : 40 - 47
12345